Simplex Trading
NRIX icon

Simplex Trading’s Nurix Therapeutics NRIX Stock Holding History

Simplex Trading’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.8K Hold
900
– – ﹤0.01% 7030
2026
Q1 		$13.9K Sell
900
-1,400
-61% -$23.2K ﹤0.01% 7055
2025
Q4 		$43.6K Buy
+2,300
New +$33K ﹤0.01% 5786
2025
Q3 		– Sell
-3,900
Closed -$44K – 9729
2025
Q2 		$44K Buy
3,900
+3,700
+1,850% +$40K ﹤0.01% 6046
2025
Q1 		$2K Sell
200
-1,100
-85% -$18.4K ﹤0.01% 8032
2024
Q4 		$24K Buy
+1,300
New +$29.8K ﹤0.01% 6539
2024
Q3 		– Sell
-3,400
Closed -$70K – 9219
2024
Q2 		$70K Buy
3,400
+3,300
+3,300% +$51.4K ﹤0.01% 5736
2024
Q1 		$1K Buy
+100
New +$1.08K ﹤0.01% 8611
2022
Q4 		– Sell
-100
Closed -$1K – 10008
2022
Q3 		$1K Buy
+100
New +$1.58K ﹤0.01% 9591
2022
Q1 		– Sell
-100
Closed -$2K – 11085
2021
Q4 		$2K Sell
100
-400
-80% -$12.1K ﹤0.01% 10016
2021
Q3 		$13K Hold
500
– – ﹤0.01% 8764
2021
Q2 		$13K Buy
500
+494
+8,233% +$14.5K ﹤0.01% 8923
2021
Q1 		$18K Buy
+6
New +$227 ﹤0.01% 7538

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Simplex Trading's NRIX Position: Q2 2026 in Review

Simplex Trading sold out of Nurix Therapeutics (NRIX) in Q2 2026, closing a stake of 8,113 shares — an estimated $138K sold.

Simplex Trading first reported a position in NRIX in Q1 2021 and held it in 16 quarters. The position peaked at $453K in Q4 2025. 212 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Simplex Trading reported no remaining Nurix Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 8,113 Nurix Therapeutics shares in Q2 2026, an estimated $138K.
  • Simplex Trading first reported a position in Nurix Therapeutics in Q1 2021 and held it in 16 quarters.
  • Simplex Trading's Nurix Therapeutics position peaked at $453K in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.